Idiopathic pulmonary fibrosis medical therapy
|
Idiopathic pulmonary fibrosis Microchapters |
|
Differentiating Idiopathic pulmonary fibrosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Idiopathic pulmonary fibrosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis medical therapy |
|
Directions to Hospitals Treating Idiopathic pulmonary fibrosis |
|
Risk calculators and risk factors for Idiopathic pulmonary fibrosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
There is currently no consensus on the treatment of IPF. Hence, none of what follows should be taken as specific advice regarding therapy, as the latter is a decision that must be made on a case-by-case basis in individual patients.[1]
There is a lack of large, randomized placebo-controlled trials of therapy for IPF. Moreover, many of the earlier studies were based on the hypothesis that IPF is an inflammatory disorder, and hence studied anti-inflammatory agents such as corticosteroids. Another problem has been that studies conducted prior to the more recent classification of idiopathic interstitial pneumonias failed to distinguish IPF/UIP from NSIP in particular. Hence, many patients with arguably more steroid-responsive diseases were included in earlier studies, confounding the interpretation of their results.
References
- ↑ Walter, N (2006). "Current perspectives on the treatment of idiopathic pulmonary fibrosis". Proceedings of the American Thoracic Society. American Thoracic Society. 3 (4): 330–338. PMID 16738197. Retrieved 2008-03-05. Unknown parameter
|coauthors=ignored (help); Unknown parameter|month=ignored (help)